HA
NTUS

Harfst & Associates’s Natus Medical Inc NTUS Stock Holding History

Harfst & Associates’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,565
Closed -$123K – 261
2015
Q4 		$123K Buy
2,565
+359
+16% +$16.6K 0.05% 122
2015
Q3 		$87K Buy
2,206
+624
+39% +$26.5K 0.04% 141
2015
Q2 		$67K Buy
+1,582
New +$63K 0.04% 156

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harfst & Associates's NTUS Position: Q1 2016 in Review

Harfst & Associates sold out of Natus Medical Inc (NTUS) in Q1 2016, closing a stake of 2,565 shares — an estimated $123K sold.

Harfst & Associates first reported a position in NTUS in Q2 2015 and held it in 3 quarters. The position peaked at $123K in Q4 2015. 207 funds tracked by Wall St. Rank hold NTUS as of Q1 2016.

  • Harfst & Associates reported no remaining Natus Medical Inc position as of Q1 2016 after selling out during the quarter.
  • Harfst & Associates sold 2,565 Natus Medical Inc shares in Q1 2016, an estimated $123K.
  • Harfst & Associates first reported a position in Natus Medical Inc in Q2 2015 and held it in 3 quarters.
  • Harfst & Associates's Natus Medical Inc position peaked at $123K in Q4 2015.
  • 207 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2016.

Based on Harfst & Associates's 13F filing for Q1 2016, filed 3 May 2016.